Dr. Yu Baofa iyo koox ka socota Maraykanka ayaa maqaal ku daabacay Joornaalka Cilmi-baarista iyo Dhaqanka Gastroenterology 

Ujeedada daraasaddan waxay ahayd in la qiimeeyo muhiimada kiliinikada ee autoantibodies ka dhanka ah GNA11, MSLN, GNAS, CEBPA, MDM2, p16, Sui1, Calnuc, PTEN ee kansarka ganaca (PC). Wadarta 33 muunadaha serum ee bukaannada PC-ga iyo 45 muunadaha serum ee kontaroolada caadiga ah (NC) ayaa lagu soo daray, iyo 9 nooc oo autoantibodies ah ayaa la ogaaday iyadoo la adeegsanayo baaritaanka difaaca jirka ee enzyme-linked (ELISA). Qiimee adiga oo isticmaalaya halbeegyo badan oo shakhsi ah ama qaab la isku daray. Marka laga reebo anti GNAS iyo anti calNUC, heerarka dhammaan autoantibodies kale ayaa aad uga sarreeya kuwa kooxda kantaroolka caadiga ah. Marka la barbardhigo kooxda kantaroolka caadiga ah (4.9%), inta jeer ee afar autoantibodies, MSLN, p16, PTEN, iyo Sui1, ayaa si weyn u kordhay, 75.8%, 66.7%, 30.3%, iyo 27.3%, siday u kala horreeyaan. Awoodda autoantibodies-yadan si ay u kala soocaan aagga hoos yimaada qalooca ROC (AUC) waxay u dhexeysaa 0.666 ilaa 0.884, oo leh anti-p16 (AUC of 0.884) iyo anti MSLN (AUC of 0.857) oo muujinaya waxqabadka ogaanshaha ugu xoogan. Isku darka anti-MSLN iyo anti-p16 waxay hagaajin karaan dareenka cudurka.